Company | Name | Exchange | Sector | Industry | Market Cap | P/E Ratio | PEG Ratio | Last Trade Price | Day Change (%) | Fair Value | Fair Value Upside | Fair Value Label | Analyst Price Target | Analyst Target Upside | Overall Health |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Sanofi | Paris | Healthcare | Pharmaceuticals | €114.59B | 14.3x | -0.51 | €91.47 | 0.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 26.2% Upside | Upgrade to Pro+ | |
EssilorLuxottica | Paris | Healthcare | Healthcare Equipment & Supplies | €104.96B | 45.3x | -12.99 | €230.50 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -3.6% Downside | Upgrade to Pro+ | |
Sartorius Stedim | Paris | Healthcare | Healthcare Equipment & Supplies | €17.52B | 107.5x | -1.65 | €180.10 | -0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 19% Upside | Upgrade to Pro+ | |
Biomerieux | Paris | Healthcare | Healthcare Equipment & Supplies | €11.51B | 28x | 4.2 | €97.55 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 24.4% Upside | Upgrade to Pro+ | |
Ipsen | Paris | Healthcare | Pharmaceuticals | €9.12B | 13.5x | 0.27 | €111.20 | 0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 7.9% Upside | Upgrade to Pro+ | |
Eurofins Scientific | Paris | Healthcare | Healthcare Providers & Services | €9.04B | 33.3x | -1.35 | €46.89 | 0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 23.6% Upside | Upgrade to Pro+ | |
Virbac | Paris | Healthcare | Pharmaceuticals | €2.64B | 18.7x | 1 | €315 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 29.5% Upside | Upgrade to Pro+ | |
Ramsay Generale De Sante | Paris | Healthcare | Healthcare Providers & Services | €1.29B | -24x | 0.11 | €11.70 | -0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Vetoquinol | Paris | Healthcare | Pharmaceuticals | €935.95M | 19.9x | -0.98 | €79.10 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 13.9% Upside | Upgrade to Pro+ | |
Emeis | Paris | Healthcare | Healthcare Providers & Services | €874.43M | 0.3x | 0.01 | €5.42 | -2.1% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Clariane SE | Paris | Healthcare | Healthcare Providers & Services | €622.88M | -0x | 0 | €1.77 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Abivax SA | Paris | Healthcare | Biotechnology & Medical Research | €519.36M | -2.6x | -1.61 | €8.20 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Medincell | Paris | Healthcare | Pharmaceuticals | €492.16M | -19.1x | -0.69 | €16.92 | 1.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 33.5% Upside | Upgrade to Pro+ | |
Boiron | Paris | Healthcare | Pharmaceuticals | €471.39M | 20x | -0.4 | €27.15 | -2.7% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 20% Upside | Upgrade to Pro+ | |
Euroapi | Paris | Healthcare | Pharmaceuticals | €400.30M | -1.3x | 0 | €4.22 | 0.3% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | -28.9% Downside | Upgrade to Pro+ | |
Guerbet | Paris | Healthcare | Healthcare Equipment & Supplies | €317.12M | 9.7x | 0.06 | €25 | -2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Valneva | Paris | Healthcare | Biotechnology & Medical Research | €304.77M | -35.3x | -0.43 | €1.88 | -2.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Eurobio Scientific | Paris | Healthcare | Biotechnology & Medical Research | €258.12M | 42.8x | -1.73 | €25.70 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 17% Upside | Upgrade to Pro+ | |
LNA Sante SA | Paris | Healthcare | Healthcare Providers & Services | €242.85M | 10.1x | €23.75 | 0% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 28.4% Upside | Upgrade to Pro+ | ||
Sensorion SA | Paris | Healthcare | Biotechnology & Medical Research | €210.25M | -6.7x | -0.14 | €0.70 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Inventiva | Paris | Healthcare | Biotechnology & Medical Research | €208.99M | -1.2x | 0.23 | €2.40 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Lumibird SA | Paris | Healthcare | Healthcare Equipment & Supplies | €197.99M | 30.5x | -0.98 | €9 | 0.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 35.3% Upside | Upgrade to Pro+ | |
Genfit | Paris | Healthcare | Biotechnology & Medical Research | €185.49M | 8.3x | 0.05 | €3.72 | -1.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Cellectis | Paris | Healthcare | Biotechnology & Medical Research | €179.17M | -1.8x | -0.06 | €1.79 | -0.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Ose Pharma International SA | Paris | Healthcare | Biotechnology & Medical Research | €162.50M | 3.4x | 0.02 | €7.47 | 0.9% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Amplitude Surgical SAS | Paris | Healthcare | Healthcare Equipment & Supplies | €160.22M | 104.4x | -1.08 | €3.34 | -0.6% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Bastide Le Confort | Paris | Healthcare | Healthcare Providers & Services | €156.39M | -176.9x | -0.19 | €21.40 | -1.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | 36.9% Upside | Upgrade to Pro+ | |
Nanobiotix | Paris | Healthcare | Biotechnology & Medical Research | €135.58M | -3.7x | -0.08 | €2.86 | 2.2% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Innate Pharma | Paris | Healthcare | Biotechnology & Medical Research | €112.68M | -3.3x | -0.07 | €1.39 | -2.4% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | ||
Maat Pharma | Paris | Healthcare | Biotechnology & Medical Research | €108.56M | -3.7x | 0.1 | €7.74 | -0.8% | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ | Upgrade to Pro+ |